Principle of Assay
Human RRAD ELISA Kit (A302920) is a 4 hour sandwich Enzyme-Linked Immunosorbent Assay (sELISA) designed for the in vitro quantitative determination of human RRAD in serum, plasma, tissue homogenates, and other biological fluids. A 96-well microtiter plate has been pre-coated with an antibody specific for RRAD. Standards and samples are added to the wells, where RRAD binds to the immobilized capture antibody. Following incubation, unbound components are removed by washing and a biotinylated detection antibody specific for RRAD is added to the wells. The detection antibody binds the captured RRAD to form an antibody-antigen-antibody sandwich complex. After further incubation and washing, HRP-Streptavidin conjugate is added to the wells. TMB substrate solution is then added to visualize the HRP enzymatic reaction. This produces a blue-coloured product that changes to yellow following addition of acidic stop solution. The intensity of the yellow colour is directly proportional to the amount of RRAD captured in each well. The concentration of RRAD is calculated by reading the absorbance at 450 nm and comparing the values with the standard curve.